“Tangeretin suppresses HER2-driven breast cancer via PI3K/AKT/mTOR inhibition and caspase-dependent apoptosis”, Bangladesh J Pharmacol, vol. 21, no. 1, pp. 1–10, Mar. 2026, doi: 10.3329/bjp.v21i1.85717.